Monitor for any amendment to SC 13D if Trigran's intent shifts from passive to active, particularly given the company's recent revenue decline. The 5.1% stake is just above the 5% threshold, indicating a modest position rather than a strong conviction bet.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 13 $3.21entry
- T+1 · 20h ago −0.93%α +0.98% · $3.18
- T+5 · in 3d Pending
- T+20 · in 27d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Trigran Investments, Inc. and its controlling shareholders disclosed a 5.1% passive stake in MiMedx Group via a Schedule 13G filed on November 12, 2026, with beneficial ownership of 7,391,329 shares as of September 30, 2026. The filing certifies passive intent and comes 15 days after MiMedx reported a 45% YoY revenue decline in Q3 2026, suggesting the stake was accumulated during or after the earnings sell-off.
Key Financial Metrics
Key Facts
- Trigran Investments, Inc. and five individuals (Douglas T. Granat, Lawrence A. Oberman, Steven G. Simon, Bradley F. Simon, Steven R. Monieson) filed a joint Schedule 13G on November 12, 2026.
- Beneficial ownership: 7,391,329 shares of common stock, representing 5.1% of shares outstanding as of September 30, 2026.
- The filing certifies passive intent under Rule 13d-1(b), stating shares were acquired and are held in the ordinary course of business, not to change or influence control.
- The stake was accumulated by September 30, 2026, predating MiMedx's Q3 2026 earnings report (filed October 28, 2026) which showed net sales of $62M, down 45% YoY.
- Each reporting person disclaims beneficial ownership except to the extent of pecuniary interest.
Financial Impact
5.1% passive stake in MiMedx Group; no transaction value disclosed in the filing.
Risk Factors
- Passive certification could be challenged if Trigran engages with management or seeks board representation, potentially requiring conversion to SC 13D.
- The stake was accumulated before the Q3 earnings miss, raising questions about the investment thesis post-revenue decline.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001104659-26-126232 |
| Document: 0001104659-26-126232-index-headers.html | 0001104659-26-126232 |
| Document: 0001104659-26-126232-index.html | 0001104659-26-126232 |
| Document: 0001104659-26-126232.txt | 0001104659-26-126232 |
Track record
10 reports on MDXG
4 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +26.86% at T+20 after the Oct 16, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 12, 20264d ago SC 13G Neutral 4/10 Viewing Entry $3.21 Now $3.18 −0.93% settles Nov 20
- Oct 28, 202619d ago 8-K Bearish 6/10 No price data
- Oct 28, 202619d ago Press Release Bearish 6/10 Entry $3.97 to $3.28 Now $3.18 +19.90% ▲ +17.38% +12.65% vs SPY
- Oct 28, 202619d ago Press Release Bullish 5/10 Entry $3.97 to $3.28 Now $3.18 −19.90% ▼ −17.38% −12.65% vs SPY
- Oct 16, 20264w ago 425 Mixed 5/10 Entry $4.43 to $3.91 Now $3.18 −28.22% ▼ −11.74% −11.83% vs SPY
- Oct 16, 20264w ago 8-K Bearish 6/10 Entry $4.43 to $3.91 Now $3.18 +28.22% ▲ +11.74% +11.83% vs SPY
- Jun 2, 202624w ago Court Ruling Bullish 5/10 Entry $3.57 to $3.71 Now $3.18 −10.92% ▲ +3.92% +6.89% vs SPY
- Apr 29, 202628w ago DEFA14A Neutral 3/10 Entry $3.36 to $3.66 Now $3.18 −5.36% ▲ +8.93% +7.20% vs SPY
- Apr 22, 202629w ago Press Release Neutral 1/10 Entry $3.31 to $3.27 Now $3.18 −3.93% ▼ −1.36% −1.41% vs SPY
- Apr 16, 202630w ago 8-K Bearish 7/10 Entry $3.43 to $3.35 Now $3.18 +7.29% ▲ +2.33% +3.32% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers